
Liquid biopsies, including circulating tumor cells, extracellular vesicles (EVs), and cell-free DNA, emerge as promising diagnostic biomarkers for RCC. Among these, EV assays exhibit the highest potential due to biological abundance, sensitivity in detecting low-volume disease, and suitability for diverse analytical applications.
Like
Save
Share